Back in 2010, it was all about soba noodles, velvet cake and cured meats. Today, it's oat milk, CBD, the Impossible Burger, acai bowls, and street corn.
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.
He talks about which metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.
...
He gives us a preview of his presentation on what's new in treatment of ulcerative colitis, including JAK and IL-12/23 inhibitors, which he will give at the virtual AIBD 2020 regional meeting on August 22.
...
